Arjuna Therapeutics
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
780 Sir Francis Drake Blvd, San Anselmo,...Phone Number
(415) 455-3324Website
www.arjunatherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Arjuna Therapeutics
Arjuna Therapeutics is an innovative biotechnology company focused on developing a new class of small molecules known as Therapeutic Molecular Clusters for cancer treatment. Their lead drug, Ag5, is designed to act as a mitochondrial-specific antioxidant deactivator, aiming to prolong the lifespan of patients with clinical stage cancer and redefine standard care for solid tumors. The company’s mission is to alleviate the fear associated with cancer diagnoses for patients and their families. Arjuna Therapeutics targets multiple cancer indications by utilizing a novel approach that influences cellular reactions without being permanently altered.Explore more
Popular SearchesArjuna TherapeuticsarjunatherapeuticsTheSIC Code 28,283NAICS Code 32,325Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Arjuna Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Arjuna Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Arjuna Therapeutics
Check out if Arjuna Therapeutics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Arjuna Therapeutics recently announced quarterly report
Click to see if Arjuna Therapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Arjuna Therapeutics has new funding data
Check if Arjuna Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Arjuna Therapeutics launches new products
Recommended Actions
Reach out to Masked Content who joined Arjuna Therapeutics as Masked Content
Find 3 more new buyers
Compare Similar Companies to Arjuna Therapeutics
Compare insights from companies similar to Arjuna Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Arjuna Therapeutics
<$5M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
Arjuna Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Arjuna Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Arjuna Therapeutics.
Arjuna Therapeutics Tech Stack
A closer look at the technologies used by Arjuna Therapeutics
Arjuna Therapeutics News & Media
ARJUNA Therapeutics Partner with Oxford Researchers to Tackle Paediatric Brain Cancer
Collaboration Carried Out With Support from Brain Research UK
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Arjuna Therapeutics
Sign Up For FreeTo access detailed company insights
Arjuna Therapeutics is an innovative biotechnology company focused on developing a new class of small molecules known as Therapeutic Molecular Clusters for cancer treatment. Their lead drug, Ag5, is designed to act as a mitochondrial-specific antioxidant deactivator, aiming to prolong the lifespan of patients with clinical stage cancer and redefine... Read More
